Detalles de la búsqueda
1.
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy.
Blood;
143(18): 1807-1815, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237147
2.
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.
Vox Sang;
119(1): 27-33, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37986640
3.
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma.
Vox Sang;
118(4): 296-300, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36734378
4.
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study.
Transplant Cell Ther;
29(12): 747.e1-747.e10, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659694
5.
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Front Immunol;
14: 1165759, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37304258
6.
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
Front Immunol;
13: 855730, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35911769
Resultados
1 -
6
de 6
1
Próxima >
>>